Pine, a rapidly ascending AI platform that acts as an autonomous digital agent for consumers, today announced the successful close of a $25 million Series A funding round. The financing, which positions Pine to scale its unique “ask-and-it’s-done” technology, was led by Fortwest Capital. Pine’s platform moves beyond the reactive nature of chatbots; it is…
In a significant leap forward for database innovation, SurrealDB has secured a substantial $20 million investment led by FirstMark and Georgian, with additional support from Crew Capital and Alumni Ventures. This latest funding round, building upon their initial $6 million seed investment, marks a pivotal moment for SurrealDB as it continues to disrupt the database…
OCON Therapeutics, a pioneer recognized by the World Economic Forum for its advancements in drug delivery, has announced a significant milestone with the completion of a $10 million investment round led by RH Capital. This funding marks a pivotal moment for OCON as it accelerates efforts to redefine the standard of care in women’s health…
Junevity, a pioneering biotechnology company with the ambitious mission of extending human healthspan through advanced cell reprogramming, today announced it has successfully expanded its Seed financing to a total of $20 million with an additional $10 million investment. The new capital was jointly led by Goldcrest Capital and Godfrey Capital, providing the runway necessary to…
Exa, a pioneering AI research lab focused on revolutionizing search capabilities for artificial intelligence, has secured $22 million in seed and Series A funding led by Lightspeed Venture Partners. This investment round also saw participation from NVentures, NVIDIA’s venture capital arm, and Y Combinator, underscoring confidence in Exa’s vision to establish itself as the foundational…
A new era of space technology dawns as Kapta Space, a Seattle-based trailblazer, emerges from stealth mode with a $5 million seed round, poised to redefine radar capabilities from orbit. Announced today, the funding—led by MetaVC Partners with support from Entrada Ventures and Blue Collective—ushers in a sophisticated leap forward in electronically-steered, radar-based imaging systems….
Rejuvenate Bio, a pioneering biotechnology firm specializing in gene therapies, announced today the reception of a $4 million grant from the California Institute for Regenerative Medicine (CIRM) to propel the development of its innovative gene therapy, RJB-0402, aimed at treating desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM). Desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM) is…
Mammha, a pioneering provider of perinatal mental health care solutions, proudly announces a significant funding infusion from the American Heart Association Social Impact Funds. This transformative support, awarded on June 5th, 2024, is poised to propel Mammha’s innovative initiatives aimed at enhancing mental health services for parents and healthcare providers nationwide. The American Heart Association’s…
Halda Therapeutics, a leading biotechnology firm renowned for its pioneering cancer therapies, has successfully raised $126 million in a Series B extension. This latest funding round saw significant participation from premier investors, including Deep Track Capital, Frazier Life Sciences, RA Capital Management, Vida Ventures, Boxer Capital, and Taiho Ventures. Existing backers such as Canaan Partners,…
In a significant stride towards sustainable industrial practices, cleantech leader GlassPoint has received a $2.5 million investment from German VC firm MIG Capital. This funding aims to bolster GlassPoint’s efforts in deploying large-scale solar steam facilities, pivotal in slashing carbon emissions across hard-to-abate sectors such as mining, chemicals, and construction materials. GlassPoint specializes in designing,…
